EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

Annals of the Rheumatic Diseases

Volumn 69, Issue 9, 2010, Pages 1596-1602

  Dixon, William G ^a   Carmona, Loreto ^b   Finckh, Axel ^c   Hetland, Merete Lund ^d   Kvien, Tore K ^e   Landewe, Robert ^f   Listing, Joachim ^g   Nicola, Paulo J ^h   Tarp, Ulrik ⁱ   Zink, Angela ^g   Askling, Johan ^j  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIDAD DE INVESTIGACIÓN   (Spain)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e DIAKONHJEMMET HOSPITAL   (Norway)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g German Rheumatism Research Centre   (Germany)

^h UNIVERSITY OF LISBON   (Portugal)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956026744     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.125526     Document Type: Article

References (12)

1. Zink A, Askling J, Dixon WG, et al. European biologicals registers: methodology, selected results and perspectives. Ann Rheum Dis 2009;68:1240-6.
2. Listing J, Strangfeld A, Kary S, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005;52:3403-12. (Pubitemid 41612206)
3. Askling J, Fored CM, Brandt L, et al. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis 2007;66:1339-44.
4. Dixon WG, Symmons DP, Lunt M, et al. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum 2007;56:2896-904.
5. Sillanpää MJ, Auranen K. Replication in genetic studies of complex traits. Ann Hum Genet 2004;68:646-57. (Pubitemid 40028450)
6. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
7. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.
8. Gliklich RE, Dreyer NA. Registries for Evaluating Patient Outcomes: A User's Guide. AHRQ Publication Number 07-EHC001-1, 2007.
9. Jönsson B, Kobelt G, Smolen J. The burden of rheumatoid arthritis and access to treatment: uptake of new therapies. Eur J Health Econ 2008;8(Suppl 2):S61-86.
10. Gómez-Reino JJ, Carmona L, Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 2007;57:756-61. (Pubitemid 46932080)
11. Crowson CS, Therneau TM, Matteson EL, et al. Primer: demystifying risk - understanding and communicating medical risks. Nat Clin Pract Rheumatol 2007;3:181-7.
12. Maclure M, Schneeweiss S. Causation of bias: the episcope. Epidemiology 2001;12:114-22.